ACM
RGNX icon

AlphaCrest Capital Management’s Regenxbio RGNX Stock Holding History

AlphaCrest Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,000
Closed -$229K – 1376
2021
Q4 		$229K Buy
+7,000
New +$238K 0.01% 1311
2021
Q1 		– Sell
-7,500
Closed -$340K – 1286
2020
Q4 		$340K Buy
+7,500
New +$262K 0.03% 860
2020
Q1 		– Sell
-9,700
Closed -$397K – 1238
2019
Q4 		$397K Buy
9,700
+1,600
+20% +$63.2K 0.03% 917
2019
Q3 		$288K Buy
+8,100
New +$328K 0.02% 1106

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return